Trending

24/7 MN (NASDAQ: CDTX) CIDEARA THEREPEUTICS INC shares are moving up more than 14% in pre-market as they announce the submission of a NDA or new drug application to the FDA.

More than 700,000 in volume and 888 trades as of this post. The stock is bid at .79

https://www.globenewswire.com/news-release/2022/07/27/2486833/35407/en/Cidara-Therapeutics-Submits-NDA-for-Rezafungin-and-Announces-License-Agreement-with-Melinta-Therapeutics-for-Commercialization-of-Rezafungin-in-the-U-S.html

RelatedNews

Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist